Roc vs. Sux - The CURASMUR Trial

February 18, 2020 00:19:11
Roc vs. Sux - The CURASMUR Trial
Critical Care Perspectives in Emergency Medicine
Roc vs. Sux - The CURASMUR Trial

Feb 18 2020 | 00:19:11

/

Show Notes

The debate on the ideal neuromuscular blocking agent for RSI in emergency intubations rages on. In this podcast, we review the latest randomized trial comparing rocuronium with succinylcholine in out-of-hospital patients needing emergency tracheal intubation – The CURASMUR Trial. Emergency medicine airway guru Dr. Ken Butler takes us through the paper and provides his expert opinion on which NMBA you should be reaching for in your next intubation!

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

June 20, 2017 00:24:03
Episode Cover

Pediatric and Neonatal Septic Shock

Peds EM superstars Mimi Lu and Barrie Bostick join CCPEM to review the latest clinical guidelines on hemodynamic support of pediatric and neonatal septic...

Listen

Episode 0

September 16, 2021 00:29:18
Episode Cover

The TOMAHAWK Study

The COACT trial demonstrated no improvement in 90-day mortality for post-arrest patients without evidence of an ST-segment elevation MI who were randomized to immediate...

Listen

Episode 0

April 17, 2019 00:22:01
Episode Cover

Tips for the Renal Transplant Patient

Renal transplants are one of the most common organ transplants worldwide.  Renal transplant patients can quickly succumb to illness and present to the ED...

Listen